Jonathan Bendheim serves as Executive at PHIBRO ANIMAL HEALTH CORP, where they oversee executive responsibilities. Since joining the company, Jonathan Bendheim has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 15, 2025 involved receiving (via award) 3,268 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 15, 2025 | PAHC | $0 | Award | 3,268 | $N/A | Discretionary |
Jonathan Bendheim currently holds 3,268 shares of PHIBRO ANIMAL HEALTH CORP (PAHC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Bendheim has been a net neutral trader of PAHC stock. They have purchased $0 and sold $0 worth of shares.
Jonathan Bendheim's most recent insider trade was on Aug 15, 2025, when they sold 3,268 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted